Evidence map›Paper›PMID 36982034›Full record

ArticleInternational journal of environmental research and public health2023

First Known Report of

Angela Perdomo, Hattie E Webb, Marie Bugarel, Cindy R Friedman, Louise K Francois Watkins, Guy H Loneragan, Alexandra Calle

Open access · goldFull text read
In one paragraph

Article in International journal of environmental research and public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Mobile Colistin-Resistant GenesAntibiotics (Basel, Switzerland) · 2024
    Article
  2. Article
  3. Mobile Colistin Resistance (Antibiotics (Basel, Switzerland) · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Angela PerdomoSchool of Veterinary Medicine, Texas Tech University, Amarillo, TX 79409, USA.ORCID 0009-0000-5884-7253
Hattie E WebbDivision of Foodborne, Waterborne, and Environmental Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.ORCID 0000-0002-1190-7930
Marie BugarelDivision of Research and Development Resources, BioMérieux, 69795 Lyon, France.
Cindy R FriedmanDivision of Global Migration and Quarantine, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.ORCID 0000-0003-1583-4617
Louise K Francois WatkinsDivision of Foodborne, Waterborne, and Environmental Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.ORCID 0000-0002-1165-1162
Guy H LoneraganSchool of Veterinary Medicine, Texas Tech University, Amarillo, TX 79409, USA.ORCID 0000-0002-8797-1648
Alexandra CalleSchool of Veterinary Medicine, Texas Tech University, Amarillo, TX 79409, USA.ORCID 0000-0003-3894-4181
Centers for Disease Control and Prevention · USTexas Tech University · USbioMérieux (France) · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colistin is a last-resort antibiotic used to treat infections caused by multidrug-resistant Gram-negative bacteria. People with a history of travel to the Dominican Republic have become sick with pathogenic bacteria carrying the mobile colistin resistance gene,

Indexed as

EnterobacteriaceaeEscherichia coli ProteinsAnimalsAnti-Bacterial AgentsColistinDominican RepublicDrug Resistance, BacterialEscherichia coliHumansMicrobial Sensitivity TestsPlasmidsAnti-Bacterial AgentsColistinEscherichia coli ProteinsMCR-1 protein, E coliantimicrobial resistancecolistin resistanceEnterobacteriaceaeEscherichia coliIncX4mcr genes

Identifiers

PMID36982034
PMCPMC10049167
OpenAlexW4324365163

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read88
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.